MCRB – seres therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Seres Therapeutics, Inc. (NASDAQ: MCRB) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Seres Therapeutics, Inc. (NASDAQ: MCRB) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $1.25 price target on the stock.
Seres Therapeutics, Inc. (NASDAQ: MCRB) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $1.00 to $0.75. They now have a "sell" rating on the stock.
Seres Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates
Seres Therapeutics, Inc. (NASDAQ: MCRB) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Form 8-K Seres Therapeutics, Inc. For: Apr 10
Form 4 Seres Therapeutics, Inc. For: Apr 10 Filed by: Ausiello Dennis A
Form 4 Seres Therapeutics, Inc. For: Apr 10 Filed by: Graves Kurt
Form 4 Seres Therapeutics, Inc. For: Apr 10 Filed by: Fraser Claire
Form 4 Seres Therapeutics, Inc. For: Apr 10 Filed by: Kender Richard N
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.